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ABSTRACT 
Fibroblast growth factor receptor 3 (FGFR3) is a key regulator of skeletal 
development and activating mutations in FGFR3 cause skeletal dysplasias, 
including hypochondroplasia, achondroplasia and thanatophoric dysplasia. The 
introduction of the Y367C mutation corresponding to the human Y373C 
thanatophoric dysplasia type I (TDI) mutation into the mouse genome, resulted in 
dwarfism with a skeletal phenotype remarkably similar to that of human 
chondrodysplasia. To investigate the role of the activating FGFR3 Y367C mutation 
in auditory function, the middle and inner ear of the heterozygous mutant 
fgfr3Y367C/+ mice were examined. The mutant fgfr3Y367C/+ mice exhibit mild deafness 
with a significantly elevated ABR threshold for all frequencies tested. The inner ear 
defect is mainly associated with an increased number of pillar cells or modified 
supporting cells in the organ of Corti. Hearing loss in the fgfr3Y367C/+ mouse model 
demonstrates the crucial role of FGFR3 in the development of the inner ear and 
provides novel insight on the biological consequences of FGFR3 mutations in 
chondrodysplasia. 
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INTRODUCTION 
Fibroblast growth factors (FGFs) and their surface receptors regulate a 
variety of cellular processes during embryonic and postnatal development. Four 
fibroblast growth factor receptors (FGFRs) are known, and three of them are 
associated with genetic disorders in humans [1]. Among them, FGFR3 has been 
recognized as a critical regulator of endochondral bone growth. Mutations in the 
coding sequence of the FGFR3 gene have been shown to cause achondroplasia 
(ACH), the most common form of dwarfism [2], hypochondroplasia (HCH), a milder 
phenotype [3] and thanatophoric dysplasia (TD), the most severe form of dwarfism 
[4, 5]. All FGFR3 mutations examined so far result in a ligand-independent 
phosphorylation of the tyrosine kinase domain [6]. To further study the function of 
FGFR3 during development, several mouse models have been created with 
various mutations corresponding to ACH or TD phenotypes [7-12]. The different 
mouse models displayed varying degrees of disproportionate dwarfism with 
skeletal anomalies. By contrast, the mouse model lacking fgfr3 had skeletal 
overgrowth and a significant hearing loss found to be due to cochlear impairment. 
In these mice the cochlear defect consisted of a lack of differentiation and an 
incomplete development of pillar cells within the organ of Corti [13-16]. 
In vertebrates, the perception of sounds is controlled by epithelial sensory 
cells located in the cochlear region of the inner ear. The sensory epithelium forms 
the organ of Corti which mediates the auditory function in mammals and 
comprises distinct cell types arranged in precise rows that extend along the entire 
length of the cochlear spiral. The organ of Corti contains one row of inner and 
three rows of outer hair cells and several types of supporting cells, namely pillar 
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cells, Deiter’s cells, Hensen’s and Claudius’ cells [17]. Previous studies have 
demonstrated that fgfr3 is required for pillar cell development and an increase in 
number of both outer hair cells and Deiter’s cells was recently observed in the 
cochleae of fgfr3 knock out mice [16]. By contrast, ectopic activation of fgfr3 by the 
either FGF2 or FGF8 in cochlear explants induces an overexpression of pillar cells 
in the organ of Corti [14, 18].  
To investigate the impact of a constitutive activation of FGFR3 on cochlear 
development, we generated a mouse model carrying the Y367C mutation 
corresponding to the human Y373C TDI mutation. This mutation causes a ligand-
independent activation of FGFR3 in vitro [19]. Here, we show for the first time, that 
the heterozygous mutant mice exhibited an inner ear defect with a significantly 
elevated ABR threshold in addition to severe dwarfism. Histological studies of the 
organ of Corti revealed an increased number of cells with the appearance of pillar 
cells most likely derived from Deiter’s cells; we called these cells “modified Deiter’s 
cells”. Hearing loss in the fgfr3Y367C/+ mouse emphasizes the interest in addressing 
the role of FGFR3 in the development of the organ of Corti.  
 
MATERIALS AND METHODS 
Generation of fgfr3Y367C/+ mice. 
The mutant construction was generated by PCR amplification of mouse 
129Sv/Pas genomic DNA. The Y367C mutation was introduced into exon 9 of the 
mouse fgfr3 gene using oligonucleotides flanking the targeted sequence. The 
468bp PCR product containing the mutation was cloned upstream of a NEO 
cassette flanked by LoxP recombination sites (ICS vector). Two fragments of 4.1 
and 2.1 kb respectively, were added as 5’ and 3’ homology arms. An Fse I 
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restriction site was added in intron 8 for cloning purposes (-175 from exon 9) (Fig. 
1A). The construct was linearized by digestion of the polylinker upstream of the 5’ 
homology arm and electroporated in 129Sv/Pas mouse ES cells (ICS cell line). 
Genomic DNA from ES cell clones was digested with restriction enzymes and 
subjected to Southern blot analysis with either a 3’ external probe or a NEO probe 
(Fig. 1B). The presence of the mutation in the recombinant clones was confirmed 
by sequencing using oligonucleotides to the NEO cassette. The 129Sv/Pas mice 
exhibiting germ-line transmission of the Y367C mutation were crossed with CMV-
Cre mice (C57BL/6j) [20] in order to delete the NEO gene. Genotypes of the 
resulting offspring were determined by PCR analysis using primers 
1(5’GATACCAGGTTTTGAGCTCCCTGTCC-3’) and 
2(5’TCAAGCCTATGAGGCAAG GTGTGG-3’). All animal studies were conducted 
according to an Animal study protocol approved by the animal Care and Use 
Committee. 
 
Radiographs, microradiographs and scanners. 
Animals were studied at birth (P0) and at five time points (P7, P14, P21, P28 and 
P35). All animals were euthanized by asphyxiation in CO2. The skeletons were 
visualised on Kodak oncology films using a Cabinet X-ray System (Faxitron series-
Hewlett Packard) (15 sec, 35 KV and 3 mA). The heads were visualised on high 
Resolution Film SO-343 (Kodak Professional, Paris, France) using a microfocal X-
ray generator (Tubix, Paris, France) at a focal distance of 56 cm for 20 min (power 
setting 12 mA and 15 KV). Temporal bones were analysed using a micro-CT 
scanner (Skycan 1076: Skycan, Antwerp, Belgium). The X-ray source was set at 
55 kV and 179 µA, with a 0.5 mm aluminium filter and a pixel size at 17.60 µm.  
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Bone and cartilage stain. 
After removing skin, muscles and other soft tissues, the bones and heads were 
fixed in 95% ethanol and then stained with Alizarin Red and Alcian Blue, cleared 
by KOH treatment, and stored in glycerol according to standard protocols [21]. 
After several weeks, the heads were dissected and the three ossicles (malleus, 
incus and stapes) were isolated from the middle ear. 
 
General testing procedure for auditory brainstem responses (ABRs).  
Animals from a mixed background (C57BL/6j/129Sv/Pas) from 6 different litters 
were tested. Eight fgfr3Y367C/+ and wild type (WT) mice were tested, at a mean age 
of 4 weeks (3-5 weeks). Each fgfr3Y367C/+ mouse was tested with its WT control 
from the same litter. All recording sessions and data analysis were performed as 
described by Ouagazzal et al [22]. All experimental procedures were carried out 
according to European Union guidelines and were approved by the local Ethical 
Committee (CREMEAS).  
 
Immunohistological analyses.  
Isolated cochleae were fixed in 4% paraformaldehyde, decalcified in 0.5 M EDTA 
and embedded in paraffin. Sections (5 µm) were cut and stained with hematoxylin-
eosin. For immunofluorescence, sections were blocked in PBST (PBS, 5% normal 
sheep serum, 0.1% Tween) and incubated with primary antibodies overnight at 
4°C. After washing, sections were incubated with a fluo rescence labelled 
secondary antibody. The primary antibody, an anti p75 nerve growth factor 
(p75NGFR) polyclonal antibody, was purchased from Chemicon and used at a 
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dilution of 1/200. The labelled secondary antibody, Alexa fluor 568 goat anti rabbit 
antibody was purchased from Molecular Probes and used at a dilution of 1/250. 
Alexa fluor 488 Phalloidin (Molecular Probes) was used at a dilution of 1/50. Slides 
were mounted using Vectashield mounting medium with DAPI (Vector). An 
Olympus PD70-IX2-UCB microscope was used for reflected light fluorescence and 
transmitted light examination. 
 
Histological and ultrastructural analyses.  
After physiological testing, animals were decapitated and the inner ears were 
removed and fixed by immersion in 2.5% paraformaldehyde and 2.5% 
glutaraldehyde in cacodylate buffer (0.1 M, pH 7.2) overnight at 4°C. The inner 
ears were decalcified in 10% EDTA, dehydrated and then washed in cacodylate 
buffer for a further 30 min followed by post-fixation with 1% osmium tetroxide in 
0.1 M cacodylate buffer for 1 h at room temperature. The specimens were 
dehydrated through graded alcohol series and embedded in Epon 812. Semi-thin 
serial sections were cut at 2.5 µm (Leica ultracut UCT), stained with Toluidine Blue 
and observed under a light microscope (Leitz). Transmission electron microscopy 
observation was performed with a Morgagni microscope (FEI) and pictures were 
processed with the Adobe Photoshop (version 7) software. 
 
RESULTS 
Severe dwarfism in heterozygous fgfr3Y367C/+ mice.  
To study the effect of FGFR3 mutations on the development of the skeletal and 
auditory system, we introduced the Y367C mutation corresponding to the human 
TDI mutation into the mouse genome (Fig. 1A). Germline transmission was 
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confirmed in targeted ES cells (Fig. 1B). The fgfr3neoY367C/+ mice were crossed with 
CMV-CRE mice to excise the NEO sequence from the germline. The fgfr3Y367C/+ 
mice were obtained with an expected Mendelian segregation. At P0, fgfr3Y367C/+ 
mice exhibited skeletal dysplasia. The phenotype became progressively more 
pronounced as the mice got older and the fgfr3Y367C/+ mice died 6-8 weeks after 
birth. The dwarf mice exhibited a reduced length of long bone especially femur and 
tail bones, a narrow trunk, short ribs and macrocephaly (Fig. 1C). Several 
fgfr3Y367C/+ mice presented bowed tibia, fibula, ulna and radius. Histological 
examination of epiphyseal growth plates in fgfr3Y367C/+ mice showed that the 
growth plate was disorganized, the chondrocyte columns were markedly 
shortened and hypertrophic chondrocytes were reduced in number and size (data 
not shown). All these observations showed that activation of fgfr3 by the Y367C 
mutation resulted in skeletal dysplasia in mice. 
 
Auditory brainstem responses (ABRs) of fgfr3Y367C/+ mice.  
The auditory thresholds of eight fgfr3Y367C/+ and wild type (WT) mice was assessed 
at a mean age of 4 weeks using ABRs. All WT mice exhibited normal ABR 
waveforms and thresholds, although threshold variability was high as shown by 
the standard error of the mean (SEM) values ascribed to the age at testing. The 
fgfr3Y367C/+ mice displayed a significantly higher ABR threshold for frequencies 
between 3 to 50 KHz (two-way ANOVA), [F(1.6)=235.8, p<0.0001], with a 
maximum of 50 dB for the medium range frequencies, and around 30 dB for lower 
and higher frequencies indicating a mild hearing loss (Fig. 2). 
 
Imaging analysis.  
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To investigate the bases of auditory defects in fgfr3Y367C/+ mice, we examined the 
skull, the middle ear and the inner ear. The skull of fgfr3Y367C/+ mice was markedly 
reduced in size along the anteroposterior axis whereas the left-right and dorsal-
ventral axes were only slightly increased compared to WT mice. Radiographs of 
fgfr3Y367C/+ mice showed a dome-shaped skull, with a shortened skull base, a 
hypoplastic midface, a prognathic mandible and an abnormal orientation of the 
temporal bone (Fig. 3A). The fgfr3Y367C/+ and WT mice were analysed using 
temporal bone high-resolution computed tomography (HRCT). On axial views, the 
petrous part of the temporal bone of the fgfr3Y367C/+ mice appeared similar to WT 
mice during postnatal development. The computed tomography (CT) scanners 
showed normal cochlea, vestibule and internal acoustic meatus (Fig. 3B). There 
was no obvious change in size or shape of the ossicles, nor abnormality of the 
incudomallear joint, incudostapedial joint, or stapes and oval window in fgfr3Y367C/+ 
mice (data not shown). The region of the temporal bone corresponding to the 
human mastoid was poorly developed with low pneumatization in all the fgfr3Y367C/+ 
mice. Finally, the foramen magnum was displaced anteriorly as a result of the 
shortened skull base. Conventional two-dimensional (2D) imaging was used to 
study ossicles and inner ear structures of the temporal bone. To better study the 
temporal bone and their intricate interrelationships, we used CT with three-
dimensional (3D) volume rendering (VRT). Oblique or lateral 3D images showed 
similar results in fgfr3Y367C/+ mice and WT mice during the postnatal period (P0-
P42). The cochlea had a snail shell shape, the three canals of the cochlea winding 
around a central axis just over 2 1/2 times (Fig. 3C). The vestibular organs 
continued anteriorly with the cochlea and posteriorly with the semicircular canals. 
The semicircular canals formed nearly two-thirds of a circle and were enlarged 
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anteriorly to form the ampulla. The bony labyrinth was normal in WT and 
fgfr3Y367C/+ mice (Fig. 3C). 
To evaluate endochondral ossification, the three ossicles were stained with alizarin 
red and alcian blue. The malleus, which is the largest of the ossicles, lies 
anterolateral to the incus and stapes. A facet on the posterior surface of the head 
of the malleus articulates with the body of the incus. The anatomy of the ossicular 
chain in the fgfr3Y367C/+ mice was normal. However, at P0, there was a severe 
ossification delay in the cochlea of fgfr3Y367C/+ mice compared to WT mice (Fig. 
3D). At P7, we observed that the orbicular apophysis of the malleus was still 
cartilaginous in fgfr3Y367C/+ mice whereas it was ossified in WT mice. A similar 
delay was observed in the incus and the stapes (Fig. 3D). At P14, ossification of 
ossicles was complete in WT mice and slightly delayed in fgfr3Y367C/+ mice. These 
data are consistent with the results found in long bones of fgfr3Y367C/+ mice, where 
a severe ossification delay was observed at P0, P7 and P14 (data not shown).  
 
Immunohistological studies in the cochlea. 
We studied the cytoarchitecture of the organ of Corti from the first turn of the 
cochlear canal. At P0 and P7, WT and fgfr3Y367C/+ mice presented a single row of 
inner hair cells (Fig. 4A and 4D). In addition, three or four rows of outer hair cells 
and Deiter’s cells were almost consistently observed in WT and fgfr3Y367C/+ mice 
(Fig. 4A and 4D). At P0 and P7, no gross abnormalities were observed in the 
basilar and tectorial membranes and the same number of pillar and Deiter’s cells 
was stained by p75NGFR, a specific marker of supporting cells in both WT and 
fgfr3Y367C/+ mice (Fig. 4B and 4E). At P14, the tunnel of Corti was well formed by 
the pillar cells in the WT mice (Fig. 4F and 4G). By contrast, the fgfr3Y367C/+ mice 
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displayed two ectopic pillars close to the first two outer hair cells in addition to the 
two normal pillar cells. We called these pillars “modified Deiter’s cells” because no 
Deiter’s cells were present at the usual place where these supporting cells are 
expected to be. The presence of “modified Deiter’s cells” created a larger space 
between outer hair cells. Usually, the same number of outer hair cells was present 
in WT and fgfr3Y367C/+ mice (Fig. 4F and 4G).  
 
Histological and ultrastructural analyses of the cochlea. 
Light microscopy of the inner cochlear canals from WT and fgfr3Y367C/+ mice of the 
same litter at the age of 4 weeks showed clear differences at the level of the basal 
cochlea up to the first turn. In a normal cochlea, Deiter’s cells support the outer 
hair cells at their basal poles and a lateral phalanx from the Deiter’s cell projects 
upward. The nucleus of Deiter’s cell is located in the upper region of the cell body, 
while the nucleus of the outer hair cells is in the basal region of the cell body. The 
most obvious differences were observed at the level of the outer hair cells and 
Deiter’s cells. The outer hair cells look shorter and irregularly shaped. The space 
between the outer hair cells (called Nuel’s space) was broader and the tunnel of 
Corti presented a smaller opening in fgfr3Y367C/+ mice (compare Fig. 5A and 5D-E). 
The two first rows of fgfr3Y367C/+ mice outer hair cells are not supported at their 
basal poles by Deiter’s cell but replaced by a pillar-like structure called “modified 
Deiter’s cells”. This structure directly connected the basilar membrane to the top of 
the organ of Corti at the level of the cuticular plate of the outer hair cells (Fig. 5A 
and 5D-E). Some cellular characteristics of the “modified Deiter’s cells” were 
reminiscent of pillar cells, such as the number of microtubules, although a greater 
number of microtubules were fasciculated into large bundles (Fig. 5F and 5G). In 
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addition, the nucleus occupied a basal position just above the basilar membrane. 
Other features tended to correspond to Deiter’s cell characteristics such as 1) the 
large amount of cytoplasm on either side of the pillar-like structure (Fig. 5F and 
5J), and 2) outer spiral fibers running in an invagination along the lateral cytoplasm 
(Fig. 5C and 5J). On the contrary, the third outer hair cells is supported by a 
normal Deiter’s cell. As in WT mice, several afferent and efferent synaptic contacts 
were present in the fgfr3Y367C/+ mice (Fig. 5B and 5I). Ultrastructural analyses of 
outer hair cells in the apical region showed a regular cuticular plate topped with a 
bundle of stereocilia (Fig. 5H). These differences were usually restricted to the 
basal and first turn of the cochlea and progressively disappeared in the upper 
regions of the cochlea. 
 
DISCUSSION 
Fibroblast growth factor receptor 3 plays an important role in the normal 
development of the skeleton [23] and mutations in the gene are responsible for 
ACH, as well as other related conditions such as TD and HCH [2-4]. Several 
mouse models exist in which mutations in FGFR3 resulted in skeletal conditions 
that mimic the human diseases [7-12, 24]. Here, we report a novel model of 
skeletal dysplasia corresponding to the human Y373C TD mutation, generated by 
introducing a Y367C point mutation into the mouse fgfr3 gene. The analysis of the 
long bones of fgfr3Y367C/+ mice indicated that the growth plate was disorganized 
with a reduced size of the hypertrophic and proliferative zone. The fgfr3Y367C/+ mice 
displayed a narrow trunk, short limbs, a shortened skull base, a large head with 
shortened nasal bone and prognathic mandible. All of these changes result from 
the disruption of endochondral ossification in the long bone and at the base of the 
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skull. Accordingly, we observed an abnormal orientation of the temporal bone and 
a delay in ossicular chain and cochlear ossification in mutant mice.  
This study addresses the role of mutations in the FGFR3 gene on mild hearing 
loss and our data show a significantly elevated ABR threshold for all frequencies 
tested (p<0.0001) in fgfr3Y367C/+ mice. The architecture of the organ of Corti was 
modified whereby the Deiter’s cells adopted a phenotype intermediate between 
pillar cells and Deiter’s cells and we therefore called these cells “modified Deiter’s 
cells”. It is interesting to note that despite the disorganization of the organ of Corti 
in the fgfr3Y367C/+ mice, anatomical changes were restricted to a lateral region to 
the tunnel of Corti at the level of the outer hair cell region. The normal appearance 
of the inner hair cells and the tunnel of Corti may explain why the cochlea was still 
functioning [25]. 
Our results suggest that fgfr3 is important in the differentiation of progenitor cells 
into pillar cells and Deiter’s cells during cochlear development and several studies 
support this hypothesis. Ectopic activation of fgfr3 by FGF8 or FGF2 leads to the 
appearance of an extra row of pillar cells in cochlear explants [14, 18]. In addition, 
deletion of the sprouty2 gene, a negative feedback regulator of FGFRs, causes a 
cochlear phenotype similar to that of the fgfr3Y367C/+ mice. The sprouty2 knockout 
mice show extra pillar cells with a similar morphology to the “modified Deiter’s 
cells” observed in the fgfr3Y367C/+ mice [26]. Conversely, in a mouse model lacking 
fgfr3 opposite results were observed, namely a failure of pillar cell development 
and severe auditory impairment [13, 15, 16]. During the antenatal period, fgfr3 
gene is initially expressed in a population of cells located at the cochlear 
prosensory domain, whereas at birth its expression is mainly restricted to the pillar 
cells and Deiter’s cells [14-16, 18, 27]. The constitutive activation of fgfr3 may be 
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implicated in specifying the fate of progenitor cells, or induce their differentiation 
into pillar cells and/or Deiter’s cells. 
Contrary to some previous studies [18, 26], the fgfr3Y367C/+ mice did not show any 
difference in the outer hair cells in the first turn of the cochlea. We hypothesize 
that fgfr3 may not directly be required for outer hair cell differentiation. It possible 
that fgfr3 plays an indirect role in regulating the normal differentiation of outer hair 
cells by preventing a normal development of specific proteins such as Prestin or 
BMPs  important for the outer hair cell function [16]. Further studies of the 
cytoarchitecture of the organ of Corti in fgfr3Y367C/+ mice will determine the exact 
consequences of FGF signaling during development. 
In conclusion, the presence of extra pillar cells or “modified Deiter’s cells” in 
the organ of Corti in the fgfr3Y367C/+ mice is likely to be responsible for the observed 
hearing deficit. In human, conductive and sensorineural hearing loss have been 
reported in achondroplasia patients [28-30], with acute otitis media and otitis 
media with effusion as the most common causes of conductive hearing loss. At 
present no data are available to explain the sensorineural hearing loss in 
achondroplasia. The hearing loss observed in the mouse fgfr3Y367C/+ model 
suggests that similar inner ear anatomical anomalies could be present in human 
chondrodysplasia with activating FGFR3 mutations. This study provides a novel 
insight into the biological consequences of FGFR3 mutations, and prompts the 
need to pay attention to sensorineural hearing loss in chondrodysplasia.  
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Figure legends 
Figure 1: Generation of the dwarf fgfr3Y367C/+ mouse.  
 (A) The point mutation Y367C in mouse exon 9 was co-transferred with the 
neomycin gene (NEO) flanked by LoxP sites, into intron 9 through homologous 
recombination in ES cells. Once germ-line transmission was established, 
fgfr3neoY367C/+ mice were crossed with CMV-Cre mice to remove the NEO gene.  
(B) Identification of ES cells and mice carrying the fgfr3Y367C allele by Southern blot 
following digestion of genomic DNA with Bam HI and Hind III.  
(C) Radiographs in three week-old fgfr3Y367C/+ (right) and wild-type (WT) littermate 
mice (left). Note the narrow trunk, short ribs and long bones, and macrocephaly in 
the fgfr3Y367C/+ mouse. 
 
Figure 2: Auditory deficits in fgfr3Y367C/+ mice. 
Auditory Brainstem Response (ABR) thresholds from 8 fgfr3Y367C/+ mice and 8 WT 
mice at a mean age of 4 weeks (3-5 weeks). The fgfr3Y367C/+ displayed a mild 
deafness with an elevated ABR threshold for frequencies between 3 to 50 KHz. 
Vertical bars indicate S.E.M. 
 
Figure 3: Analysis of the middle and inner ear. 
(A) Microradiograph of the skull of the fgfr3Y367C/+ mouse at P14 showing a dome-
shaped skull, a shortened cranial base, a hypoplastic midface, a prognathic 
mandible (Md), an abnormal orientation of the semi circular canals (SCC), cochlea 
(Co) and foramen magnum (Fm) in the temporal bone. 
(B) High resolution computed tomography (HRCT) scanning reveals a normal 
cochlea (Co), vestibule (Ve) and internal acoustic meatus (IAM) in both WT and 
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fgfr3Y367C/+ mice at P21. The temporal bone (TB) is poorly developed in fgfr3Y367C/+ 
mice. 
(C) Three dimensional (3D) images of the bony labyrinth which consist of the 
vestibule (Ve), the semi circular canals (SCC) and the cochlea (Co) with the oval 
window (OW) and round window (RW) in three week-old fgfr3Y367C/+ and WT mice. 
(D) Staining of the bony capsule of the inner ear and the ossicles from the middle 
ear shows delayed ossification in the bony capsule of the fgfr3Y367C/+ mice at P0. 
Ossification of the cochlea (Co) was delayed in fgfr3Y367C/+ mice. At P7, the 
orbicular apophysis of the malleus (Ma) (arrow), the incus (In) and the stapes (St)  
were still cartilaginous in the fgfr3Y367C/+ mice. One week later, at P14, the ossicles 
were slightly delayed in fgfr3Y367C/+ mice and totally ossified in WT.  
 
Figure 4: Modifications of the organ of Corti in fgfr3Y367C/+ mice  
(A and B) Cross sections of the first turn of the cochlear canal through the organ of 
Corti (OC) at P0 were stained with phalloidin (green), DAPI (blue) and p75NGFR 
(red). The mutant and WT mice presented a normal number of cells in the organ of 
Corti: one inner hair cell (IHC), two pillar cells, three outer hair cells (OHC) and 
three Deiter’s cells (DC). (A: phase contrast, B: immunofluorescence). 
(C) Schematic drawing of cross-sectional views of the organ of Corti in the WT and 
fgfr3Y367C/+ mice at P0. The organ of Corti is composed of an outer pillar (OP), an 
inner pillar (IP) (orange), Deiter’s cells (DC) (red), inner hair cells (IHC) and outer 
hair cells (OHC) (green). 
(D and E) Cross sections through the organ of Corti of fgfr3Y367C/+ mice at P7 
showing the same number of cells as seen at birth in the WT mice, except for the 
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presence of four outer hair cells (OHC) in this case. P75NGFR labels pillar cells (PC) 
and Deiter’s cells (DC). 
(F) Cross-sections through the organ of Corti at P14, stained for phalloidin and 
counterstained with DAPI. Two modified Deiter’s cells (MDC) were present in the 
fgfr3Y367C/+ mice and large spaces are visible between rows of outer hair cells 
(OHC) (asterisks).  
(G) Schematic drawing of the mature organ of Corti in WT and fgfr3Y367C/+ mice at 
P14. Note the presence of two modified Deiter’s cells (MDC) (red) and large 
spaces (asterisks) between outer hair cells (OHC) in the mutant mice. 
Magnification X63 (A,B,D,E,F). 
 
Figure 5: Light and transmission electron micrographs (TEM) of 4 week old 
fgfr3Y367C/+ and WT cochleae 
(A) Light micrograph of the first turn of the cochlear canal of WT mouse. The 
cochlear canal consists of two types of sensory cells, one row of inner hair cells 
(IHC) and 3 rows of outer hair cells (OHC) separated by the tunnel of Corti (TC) 
with two pillar cells, the inner pillar (IP) and the outer pillar (OP). The inner and 
outer pillar nuclei are located on the base of the basilar membrane (BM). The large 
open space between the IP and the first OHC is termed Nuel’s space (NS). Each 
outer hair cell is supported by a Deiter’s cell (DC). The efferent fibers, called 
medial olivocochlear fibers (MOC) can be observed crossing the upper part of the 
tunnel of Corti.  
(B) Transmission electron micrograph at the synaptic pole from an outer hair cell 
(OHC) of the first row showing two efferent synapses (e), both synapses and the 
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basal pole of the outer hair cells are surrounded by a Deiter’s cell (DC) in WT 
mouse.  
(C) Transmission electron micrograph of the first Deiter’s cell (DC) showing a 
bundle of microtubules (mt) and outer spiral fibers (osf) running in an invagination 
of the lateral cytoplasm in WT mouse.  
(D) Light micrograph from the first turn of the cochlear canal from a fgfr3Y367C/+ 
mouse. The inner hair cell (IHC) is separated from outer hair cells (OHC) by the 
tunnel of Corti where the lumen appears smaller. The two first rows of outer hair 
cells are not supported at their basal poles by Deiter’s cell (DC) but are replaced 
by a pillar-like structure called “modified Deiter’s cells” (MDC). Upper efferent 
tunnel crossing fibers corresponding to medial olivocochlear fibers (MOC) are 
visible. Spaces (asterisks) between outer hair cells, called Nuel’s space (NS), are 
larger.  
(E) Light micrograph from the first turn of the cochlear canal of the fgfr3Y367C/+ 
mouse. Note that the outer hair cells (OHC) are free-standing in the space 
between the “modified Deiter’s cells” (MDC). The nucleus of the “modified Deiter’s 
cells” (white arrowhead) is situated close to the basilar membrane (BM).  
(F) Transmission electron micrographs of the boxed area a from Figure E. The first 
MDC presents a large concentration of well-oriented microtubules (mt) with 
reduced cytoplasmic area (ca).  
(G) The outer pillar (OP) is mainly composed of microtubules without much 
cytoplasm visible in boxed area b from Figure E. 
(H) Transmission electron micrograph from box c of Figure E corresponding to the 
first and second rows of outer hair cells (OHC) and the first “modified Deiter’s cell” 
(MDC).  
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(I) Transmission electron micrograph from the boxed area of Figure H from the 
synaptic pole of the outer hair cells (OHC). The “modified Deiter’s cells” (MDC) are 
in close contact with the outer hair cells (arrow heads). An outer spiral fiber (OSF) 
is seen in close contact with the MDC. Two synaptic contacts are visible below the 
outer hair cells. a: afferent, e: efferent synapses.  
(J) Transmission electron micrograph from a lateral region of the “modified Deiter’s 
cells” (MDC) from the first row showing several outer spiral fibers (OSF). 
Scale bars : B, C, G, J and I: 1µm, F: 0.5 µm, H: 5µm. 
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